Skip to main content

Making Her SMART Marks

2018 Hillenkamp Fellow Haley Marks
with the first prototypes of the oxygen-sensing hydrogels,
developed in collaboration with BU
Winning the inaugural $75,000 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biophotonics and Biomedical Optics has had its fair share of notable impact on Haley Marks' life and profession. The fellowship, which supports and provides opportunities for translating new technologies to clinical practice for improving human health was awarded for the first time in January 2018 at SPIE Photonics West.

"I actually found out that I won in December, just as I was getting ready to fly home for the holidays," she recalls. "I was packing when I got a call from Rox Anderson, the director of our center, the Wellman Center for Photomedicine, congratulating me, and I got all flustered. I swung by the lab on the way to the airport to celebrate the news with my mentor, Dr. Conor Evans, and our colleagues, and ended up missing my plane!"

The missed flight has been more than worth it for Marks, who has been at the Wellman Center since February 2017, working with Evans and his team on an oxygen-sensing bandage known as a SMART (sensing, monitoring, and release of therapeutics) bandage. "We've been working on the oxygen-sensing element from a chemistry standpoint," she explains. "This fellowship, which supports our interdisciplinary, translational work, has given us the opportunity to take new, creative approaches on the therapeutic aspect of the bandage." Previously, their oxygen sensing bandages had been created for intact skin - for conditions such as grafts, bacterial infections, chronic sun exposure, for example - utilizing different formulations of a paintable, or sprayable New Skin™-based liquid bandage: "We spent a lot of time in the arts and crafts store trying to adapt airbrushing techniques."

These days, the team is homing in on creating a bandage that doesn't just sense and monitor oxygen levels, it treats open wounds and burns as well. Upon receiving the fellowship, Marks and the Evans team established a new collaboration with Dr. Mark Grinstaff's lab at Boston University, a group with expertise in biocompatible hydrogels that specifically cater to weeping wounds. Together, the labs have already developed a number of oxygen-sensing hydrogel prototypes.

"The SPIE-Hillenkamp Fellowship means that I've been able to work on new, biocompatible materials that are open-wound friendly," says Marks. "You can place them over severe injuries like a gouge or laceration, for example, or use them in a situation where you have a wound that's oozing exudate. These new versions of the bandage are able to soak up the exudate the way a traditional bandage material would, while also releasing therapeutics to treat the wound, and providing oxygen-sensing feedback."

Demonstration of the oxygen-sensing hydrogel's response to extreme changes in environment:
left- in the absence of water and air the bandage red phosphorescence is dominant and is indicative of poor tissue health, right- when in the presence of normal levels of water and air green fluorescence is dominant

Haley gives me a mini-demo of the latest iteration of the SMART bandage: the team's sensor dyes are embedded in robust biocompatible hydrogels that start out in liquidish form - "like jello! They have the exact, same consistency as jello!" They conform to the shape of the wound and then solidify into a wound dressing. Marks shows me how the bandage, exposed to oxygen-rich room air, glows green; another one that gets a humid, oxygen-deprived environment, under nitrogen gas, glows orange, the early warning sign; and one that's exposed to a dry, oxygen-deprived environment, again, under nitrogen gas glows red.

The 'SMART' bandage can be imaged using a
commercial DSLR camera with customized filters

The 'SMART' bandage phosphorescence
emission is also visible by eye under UV light

It's cool, colorful, and impressive. So where does the translational focus fit in? That's one of the most exciting parts, notes Marks. "As a part of this fellowship I not only have my scientific advisor, Dr. Evans, I also have a translational sciences mentor, Dr. Gabriela Apiou. With Dr. Apiou, I connect with our clinical collaborators to guide designs and implement changes to ensure that we always meet clinical needs and match clinical workflows. For example, when we're choosing what type of drug to load into the new bandages, we make sure to take into account important down-the-road decisions, such as ensuring that those drugs are manufactured in a facility that functions under GMP, good manufacturing process. It's all about making sure our choices will find approval through the clinical pipeline as well as the regulatory pathway. And continuing to have that feedback loop is really helpful, ensuring that we don't go down the wrong path and spend months making what we think is a perfect product that doesn't fully address a clinical need or has the wrong form or function."

Another of Marks' favorite aspects of the fellowship thus far is an entrepreneurial series which Dr. Apiou has created, bringing together successful innovators, MDs and PhDs, from Massachusetts General Hospital every couple of months to share their translational know-how and expertise. "One of the common themes I noticed was how important it is to connect all aspects of laboratory work to the underlying clinical needs and questions. What exactly does a piece of data mean physiologically? How does data predict outcomes from treatment? If you've created a tool that can measure something better than existing devices, how does this improvement effect a doctor's daily routine? How does it impact their diagnoses, and ultimately patient outcomes? That's where this translational bridge lies," Marks continues: "It is understanding - at the start - how your experiments and your data fundamentally connect to clinical problems. That's been a really insightful aspect to the work I'm getting to do here."

That aspect is among her advice for future applicants for the fellowship: "Make sure your proposal is not just focused on the minutia of the science. While I was putting together drafts and going over them with Drs. Evans and Apiou, I had a tendency to get really deep into the details of 'this is the exact experiment that I want to do.' It's important to take a step back and look at the big picture and emphasize the translational component: how is what you are doing motivated by needs in clinical care? Successful translation is not just having doctors like an idea; there's also the business and regulatory aspects of a successful program. I've learned a ton about the types of communication needed when discussing my work in business vs clinical vs scientific settings."

Winning the fellowship was also a kind of affirmation for Marks, as it pertains to her involvement with SPIE. As a PhD candidate at Texas A&M, she was the SPIE chapter president. Actually, she notes, she's had almost every SPIE chapter role at some point: "I was the secretary and the treasurer then the VP then the president, so I was really involved in SPIE and have always loved the organization. We did a lot of K-12 outreach, and I learned most of the optics I know from trying to answer the questions of young kids and their parents, and trying to format new demos every year to keep things interesting. That side of SPIE, the K-12 outreach, is this whole other side of SPIE that I think people don't see often enough. I've always loved the SPIE's mission to make photonics a less scary word and to keep kids excited about light and light-based sciences."

Or even, it seems, keeping post-graduate researchers excited about - and engaged with - the life-healing properties of light.



All photos are courtesy of the Wellman Center for Photomedicine

Learn more about the SPIE-Franz Hillenkamp Fellowship in Problem Driven Biophotonics and Biomedical Optics. Applications for the 2019 fellowship are due 7 September 2018.

Comments

Popular posts from this blog

Changing life as we know it: the Internet of Things and cyber-physical sensing

More than 20 billion Internet of Things (IoT) devices are expected to be deployed within the next few years; by 2025, this number may reach as much as 1 trillion connected devices. Driven by growth in cloud computing, mobile communications, networks of data-gathering actuators and sensors, and artificial intelligence with machine learning, this trend will change how we live our lives.
Already we live among connected devices in our homes.

Increasingly, we will also wear them, drive them, and monitor our health via the IoT. More businesses will build, ship, and design products and manage inventory with connected devices. In our cities, transportation, communications, and security infrastructure, and services such as water distribution and energy management will employ IoT applications. Farmers will find many uses, from insuring the health of livestock to increasing crop productivity.
Several conferences scheduled for SPIE Defense + Commercial Sensing 2018 (15 through 19 April in Orland…

Hyperspectral imaging: defense technology transfers into commercial applications

Hyperspectral imaging, like many other of today's technologies, is moving into numerous commercial markets after developing and maturing in the defense sector. While still having a strong presence in defense applications, the technology is now used in chemical detection, food quality assurance and inspection, vegetation monitoring, and plant phenotyping, among others.
For more than 20 years, advances in spectral imaging have been on display at SPIE Defense + Commercial Sensing (DCS). The applications and capabilities of the technology have grown along with the conferences and exhibition at SPIE DCS.
The ability to see more than what is visible to the human eye has always been one of the goals of optical engineers. With hyperspectral imaging they have been able to achieve just that. By accessing the entire electromagnetic spectrum, the sensors are able to image a specific wavelength range, or spectral band, and combine images of multiple bands into one 3D scene.
Through analysis,…

Glass ceiling, sticky floor: countering unconscious bias in photonics

Who knew … until last year: Three African-American women working — in obscurity — for NASA as mathematicians played a vital role in the mission that sent astronaut John Glenn into orbit around Earth and brought him back again, in 1962.
Publication of Margot Lee Shetterly's book Hidden Figures and the subsequent release of the acclaimed 2016 film brought the story of the important roles played by Katherine Johnson, Dorothy Vaughan, and Mary Jackson to light for the first time for many.
While their story may have been little known for decades, struggles for opportunity and inclusion are familiar to many women and to members of under-represented minorities or other groups working to make a career in a STEM (science, technology, engineering, and mathematics) field.
Findings on gender equity from the latest SPIE Optics and Photonics Global Salary report indicate that women in the field lag behind men in salary and in representation in management and senior academic positions.
The cost…